Search Results - "Kovalevskaya, O. B."

Depression and severity of articular destruction in patients with rheumatoid arthritis by Abramkin, A. A., Lisitsyna, T. A., Veltishchev, D. Yu, Seravina, O. F., Kovalevskaya, O. B., Glukhova, S. I., Nasonov, E. L.

“…Aim. To assess the influence of anxiety and depressive disorders on joint destruction in patients with rheumatoid arthritis (RA). Materials and methods. 128…”
Get full text

Chronic pain and depression in patients with rheumatoid arthritis: results of five - year follow - up by Lisitsyna, T A, Abramkin, A A, Veltishchev, D Yu, Seravina, O F, Kovalevskaya, O B, Zeltyn, A E, Glukhova, S I, Nasonov, E L, Krasnov, V N

“…The aim of the study was to analyze the factors affecting chronic pain in patients with rheumatoid arthritis (RA). Materials and methods. 128 patients with…”
Get full text

Comparative analysis of anxiety-depressive spectrum disorders in patients with rheumatic diseases by Lisitsyna, T A, Veltishchev, D Yu, Seravina, O F, Kovalevskaya, O B, Starovoytova, M N, Desinova, O V, Abramkin, A A, Ovcharov, P S, Vasil'ev, V I, Alekberova, Z S, Krasnov, V N, Nasonov, E L

“…Research objective - comparative analysis of incidence and structure of anxiety-depressive spectrum disorders (ADD) in patients with various rheumatic diseases…”
Get full text

Chronic stress and mental disorders in patients with systemic scleroderma: Results of an interdisciplinary study by Seravina, O F, Lisitsyna, T A, Starovoytova, M N, Desinova, O V, Kovalevskaya, O B, Veltishchev, D Yu

“…To analyze of the prevalence of stressful factors and mental disorders (MDs), as well as their clinical psychopathological and clinical psychological…”
Get full text

Efficacy of Olokizumab against Comorbid Depressive Disorder in Patients with Rheumatoid Arthritis: Preliminary Results of the Study by Lisitsyna, T. A., Abramkin, A. A., Veltishchev, D. Yu, Seravina, O. F., Kovalevskaya, O. B., Borisova, A. B., Ignatiev, V. G., Nasonov, E. L.

“…Interleukin (IL) 6 plays an important role in the pathogenesis of depression comorbid with rheumatoid arthritis (RA), and IL-6 inhibitors used to treat…”
Get full text

Efficacy of olokizumab against comorbid depressive disorder in patients with rheumatoid arthritis: Preliminary results of the study by Lisitsyna, T. A., Abramkin, A. A., Veltishchev, D. Yu, Seravina, O. F., Kovalevskaya, O. B., Borisova, A. B., Ignatiev, V. G., Nasonov, E. L.

“…Background . Interleukin (IL) 6 plays an important role in the pathogenesis of comorbid rheumatoid arthritis (RA) depression, and IL-6 inhibitors (i) used to…”
Get full text

Mental disorders and cognitive impairment in patients with antiphospholipid syndrome by Borisova, A. B., Lisitsyna, T. A., Veltishchev, D. Yu, Reshetnyak, T. M., Seravina, O. F., Kovalevskaya, O. B., Krasnov, V. N., Nasonov, E. L.

“…Mental disorders (mainly anxiety and depressive disorders) and cognitive impairment are often found in patients with antiphospholipid syndrome (APS), but their…”
Get full text

Risk factors and prevention of recurrent dynamics of depression by Veltishchev, D Yu, Kovalevskaya, O B, Seravina, O F

“…The existing literature in the field demonstrates that in the majority of cases depressive disorder has a recurrent course that resulted in negative…”
Get more information

EFFECTS OF SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS, BIOLOGICAL AGENTS, AND PSYCHOPHARMACOTHERAPY ON THE MENTAL DISORDERS IN PATIENTS WITH RHEUMATOID ARTHRITIS by Abramkin, A. A., Lisitsyna, T. A., Veltishchev, D. Yu, Seravina, O. F., Kovalevskaya, O. B., Nasonov, E. L.

“…Mental disorders (MDs) of the anxiety-depressive spectrum (ADS) and cognitive impairment (CI) are characteristic of the majority of patients with rheumatoid…”
Get full text

Cognitive disorders in Behçet's disease by Ovcharov, P S, Lisitsyna, T A, Veltishchev, D Yu, Burenchev, D V, Ishchenko, D A, Seravina, O F, Kovalevskaya, O B, Alekberova, Z S, Nasonov, E L

“…To study the prevalence of cognitive disorders (CD) and clinical/pathogenetic correlations of CD in patients with Behçet's Disease (BD). One hundred and six BD…”
Get more information

THE IMPACT OF ADEQUATE PSYCHOPHARMACOTHERAPY ON THE EFFICIENCY OF TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS by A. A. Abramkin, T. A. Lisitsyna, D. Yu. Veltishchev, O. F. Seravina, O. B. Kovalevskaya, E. L. Nasonov

“…Mental disorders (MDs) of the anxiety-depressive spectrum (ADS) and cognitive impairment (CI) substantially deteriorate the course and efficiency of therapy…”
Get full text

FACTORS INFLUENCING THE EFFICIENCY OF THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS: THE ROLE OF COMORBID MENTAL AND SOMATIC DISEASES by Abramkin, A. A., Lisitsyna, T. A., Veltishchev, D. Yu, Seravina, O. F., Kovalevskaya, O. B., Glukhova, S. I., Nasonov, E. L.

“…The response rate to therapy for rheumatoid arthritis (RA) rarely exceeds 60%. Mental disorders (MDs) of the anxiety-depressive spectrum (ADS) and cognitive…”
Get full text

FACTORS ASSOCIATED WITH ANXIETY AND DEPRESSION SPECTRUM DISORDERS IN BEHCHET’S DISEASE by Ovcharov, P. S., Lisitsyna, T. A., Veltishchev, D. Yu, Seravina, O. F., Kovalevskaya, O. B., Glukhova, S. I., Alekberova, Z. S., Nasonov, E. L.

“…Objective : to determine the main factors associated with the development and manifestations of anxiety and depression spectrum disorders (ADSDs) in patients…”
Get full text

Proinflammatory cytokines and depression in rheumatoid arthritis by Lisitsyna, Tatyana Andreyevna, Veltishchev, D Yu, Seravina, O F, Kovalevskaya, O B, Zeltyn, A E, Novikov, A A, Aleksandrova, E N, Krasnov, V N, Nasonov, E L

“…Objective: to specify the association between the levels of proinflammatory cytokines, such as tumor necrosis factor-а (TNF-а), interleukin-1 β (IL-1 β), and…”
Get full text

The magnitude of fatigue and its association with depression, pain, and inflammatory activity in rheumatoid arthritis by Lisitsyna, T A, Veltishchev, D Yu, Gerasimov, A N, Seravina, O F, Kovalevskaya, O B, Zeltyn, A E, Novikov, A A, Aleksandrova, E N, Tallerova, A V, Kovalenko, L P, Durnev, A D, Krasnov, V N, Nasonov, E L

“…To analyze the rate of clinically significant fatigue and to search for its predictors in patients with rheumatoid arthritis (RA). The investigation included…”
Get full text

Objective: to specify the frequency and pattern of mental disorders in patients with rheumatoid arthritis (RA) and their association with a number of demographic parameters, stressors, inflammatory activity, duration of RA and its therapy, pain, and concomitant cardiovascular diseases (CVD).Subject and methods. One hundred and sixteen patients with verified RA were examined; 86% were women with a median age of 50 years (range, 41 to 55 years) and a median RA duration of 94.5 months (range, 45 to by Lisitsyn, T A, Veltishchev, D Yu, Seravina, O F, Kovalevskaya, O B, Zeltyn, A E, Fofanova, Yu S, Novikova, D S, Popkova, T V, Nasonov, E L

Get full text

Prevalence of mental disorders in SLE patients: correlations with the disease activity and comorbid chronic conditions by Lisitsyna, T A, Vel'tishchev, D Iu, Seravina, O F, Kovalevskaia, O B, Marchenko, A S, Novikova, D S, Novikov, A A, Aleksandrova, E N, Nasonov, E L

“…To study effects of the disease activity and comorbid chronic conditions on the incidence of mental disorders in patients with systemic lupus erythematosus…”
Get full text

Variants of psychiatric disorders in patients with systemic lupus erythematosus by Lisitsyna, T A, Veltishev, D Y, Seravina, O F, Kovalevskaya, O B, Marchenko, A S, Nasonov, E. L.

“…Objective. To analyze prevalence and structure of psychiatric disorders in pts with systemic lupus erythematosus (SLE) examining in the Institute of…”
Get full text

Successful psychopharmacotherapy of anxiety and depressive disorders improve functional limitations in patients with rheumatoid arthritis by Abramkin, A A, Lisitsyna, T A, Veltishchev, D Y, Seravina, O F, Kovalevskaya, O B, Glukhova, S I, Nasonov, E L

“…To compare changes in functional limitations in patients with rheumatoid arthritis (RA) and comorbid anxiety and depressive disorders (ADD) treated with…”
Get full text

Influence of successful psychopharmacotherapy of anxiety-depressive spectrum disorders on the severity of chronic fatigue in patients with rheumatoid arthritis by Abramkin, Anton A., Lisitsyna, Tatiana A., Veltishchev, Dmitrii Y., Seravina, Olga F., Kovalevskaya, Oksana B., Glukhova, Svetlana I., Nasonov, Evgeny L.

“…Aim. To assess the influence of psychopharmacotherapy (PPT) of anxiety and depressive disorders on fatigue severity in patients with rheumatoid arthritis (RA)…”
Get full text